image
Virpax Pharmaceuticals, Inc. VRPX
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 0.6142
-4.72 %
$ 3 M
Market Cap
-0.05
P/E
BALANCE SHEET
9.63 M ASSETS
-51.06%
Growth Rates
1Year -51.06%
3Years 174.52%
5Years 174.75%
7Years 0.00%
10Years 0.00%
7.69 M LIABILITIES
148.63%
Growth Rates
1Year 148.63%
3Years 18.01%
5Years 43.73%
7Years 0.00%
10Years 0.00%
1.93 M EQUITY
-88.33%
Growth Rates
1Year -88.33%
3Years 34.97%
5Years 29.36%
7Years 0.00%
10Years 0.00%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Virpax Pharmaceuticals, Inc.
image
Current Assets 9.63 M
Cash & Short-Term Investments 9.14 M
Receivables 0
Other Current Assets 487 K
Non-Current Assets 0
Long-Term Investments 0
PP&E 0
Other Non-Current Assets 0
Current Liabilities 7.69 M
Accounts Payable 18.5 K
Short-Term Debt 0
Other Current Liabilities 7.68 M
Non-Current Liabilities 0
Long-Term Debt 0
Other Non-Current Liabilities 0

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018
ASSETS
Cash & Cash Equivalents 9.1 19.0 36.8 54.8 K 41.5 K 48.4 K
Short Term Investments 0 0 0 0 0 0
Receivables 0 0 0 0 1.39 K 0
Inventory 0 0 0 0 3.33 K 0
Other Current Assets 0.5 0.7 2.7 18.3 K 3.8 K 13.1 K
Total Current Assets 9.6 19.7 39.6 73.1 K 46.7 K 61.5 K
PP&E 0 0 0 0 0 0
Intangible Assets 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0
Long Term Investments 0 0 0 0 0 0
Other Long Term Assets 0 0 0 0.4 0 0
Other Assets 0 0 0 0 0 0
Total Assets 9.6 19.7 39.6 0.5 46.7 K 61.5 K
LIABILITIES
Accounts Payable 18.5 K 37.6 K 19.8 K 22.1 K 3.5 K 6.55 K
Short Term Debt 0 0 0 0.5 1.3 0.5
Other Current Liabilities 7.7 3.1 2.1 3.1 1.5 0.7
Total Current Liabilities 7.7 3.1 2.1 3.7 2.8 1.3
Long Term Debt 0 0 0 1.0 0 0
Deferred Tax Income 0 0 0 0 0 0
Other Liabilities 0 0 0 0 0 0
Total Liabilities 7.7 3.1 2.1 4.7 2.8 1.3
EQUITY
Common Stock 12 117 117 31 30 29
Retained Earnings (59.5) (44.4) (22.7) (10.6) (6.3) (3.0)
Other Accumulative Comprehensive Income/Loss 0 0 0 0 0 0
Total Equity 1.9 16.6 37.5 (4.2) (2.7) (1.2)
Total Liabilities and Equity 9.6 19.7 39.6 0.5 46.7 K 61.5 K
SHARES OUTSTANDING
Common Shares Outstanding 1.2 1.2 1.2 0.5 0.5 4.9